COMMUNIQUÉS West-GlobeNewswire

BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
13/11/2018
CAMBRIDGE, Mass., and BEIJING, China, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
How Sentara Healthcare is Removing Boundaries through PACS Modernization with Client Outlook and Mach7
13/11/2018
WATERLOO, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Client Outlook Inc. and Mach7 Technologies (Mach7) announced today they have been selected to spearhead Sentara Healthcare’s PACS Modernization project. This [...]
Aravive Presents Detailed Results of Phase 1 Clinical Trial of AVB-S6-500 at the 2018 EORTC-NCI-AACR Symposium
13/11/2018
HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced detailed results of its first-in-human Phase 1 clinical trial of AVB-S6-500 in healthy [...]
RedHill Biopharma Reports Third Quarter 2018 Financial Results and Business Highlights
13/11/2018
Key Highlights: Top-line results from the confirmatory Phase III study with TALICIA ® for H. pylori infection are on track to be announced by year-end 2018, with potential NDA filing in early 2019 Positive top-line [...]
Cybrexa Therapeutics Presents Preclinical Data Demonstrating its alphalex™ Tumor Targeting Platform Delivers a High Dose of PARP Inhibitor in Combination with Chemotherapy
13/11/2018
Synergistic combination selectively kills tumors and prevents bone marrow toxicities Poster presentation today during 30 th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium Marks initial introduction [...]
Cerecor Reports Third Quarter 2018 Results
13/11/2018
BALTIMORE, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (“Cerecor” or the “Company”) (NASDAQ: CERC), a fully integrated biopharmaceutical company with commercial operations and research and development capabilities, [...]
Aran Biomedical Pioneers breakthrough medical textiles valve covering technology; ValvTEX™
13/11/2018
GALWAY, Ireland, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Aran Biomedical, a trusted partner in design, development and manufacture of implantable medical devices, today announced its new medical textile valve covering [...]
AC Immune Reports Third Quarter 2018 Financial Results and Corporate Update
13/11/2018
Announced important clinical milestones for ACI-24 vaccine in Alzheimer's disease and Down Syndrome Company record high, period end cash position of approximately CHF 200 million that is expected to extend our cash [...]
LIDDS receives approval from MPA to start Phase I study NZ-DTX-001
13/11/2018
The Swedish Medical Product Agency has approved a first-in-human study, NZ-DTX-001, in which solid tumors will be treated with NanoZolid combined with docetaxel. This is LIDDS' second clinical project and will initially [...]
Ambu A/S: Annual Report 2017/18 (Earnings release)
13/11/2018
Ambu ends the year with 15% organic growth and an EBIT margin of 21.6%. Following a 2.5 percentage point EBIT margin increase, Ambu is on track to realising the targets of its 2020 strategy. "We have now come to the end [...]
PCI Biotech: Third quarter 2018 results
13/11/2018
Oslo (Norway), 13 November 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim third quarter 2018 result. Please find enclosed the report and presentation. The fully [...]
Kiadis Pharma to present at upcoming investor conferences in November 2018
13/11/2018
Kiadis Pharma to present at upcoming investor conferences in November 2018 Amsterdam, The Netherlands, November 13, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a [...]
Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP and Reports Third Quarter 2018 Financial Results
13/11/2018
Phase 2/3 Expansion Study to Include No-Sham Control Arm in Alignment with FDA Draft Guidance on Development of Gene Therapy Products for Retinal Disorders Preliminary Efficacy Data from Phase 2/3 Expansion Study [...]
Sharecare and Gallup announce 2017 state and community rankings for diabetes prevalence
13/11/2018
Zero U.S. states lower obesity and diabetes rates in ten-year period ATLANTA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company that helps people manage all their health in one place, and world- [...]
First quantitative diagnostic test validated for Treatment-Free Remission for Eligible Patients with Ph+ CML-CP Treated with Tasigna® Cleared by Health Canada
13/11/2018
PORTLAND, Ore. and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- MolecularMD Corporation received regulatory approval from Health Canada for the MRDx ® BCR-ABL Test, a quantitative diagnostic test used as an aid [...]
CORRECTION: Unum Therapeutics to Host Investor Event on its Efforts to Realize the Promise of T Cell Therapies in Solid Tumors
13/11/2018
CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Unum Therapeutics Inc. (NASDAQ: UMRX), please note the investors event date has been changed from November [...]
Corizon Health Launches Dedicated Military Recruiting Team
12/11/2018
BRENTWOOD, Tenn., Nov. 12, 2018 (GLOBE NEWSWIRE) -- In recognition of Veteran’s Day, Corizon Health today announced creation of a recruiting team dedicated to bringing US military veterans into its healthcare ranks. “ [...]
TOMI Environmental Solutions, Inc. to Hold Third Quarter 2018 Financial Results Conference Call on Monday, November 19, 2018
12/11/2018
BEVERLY HILLS, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global provider of infection prevention and decontamination products, services and research, including [...]
Eton Pharmaceuticals Announces Pricing of Initial Public Offering
12/11/2018
DEER PARK, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced the [...]

Pages